Alfasigma SpA signs €170m deal with Galapagos NV
Following its announcement from Oktober 2023 to take over the filgotinib business from Galapagos NV, Bologna-based Alfasigma SpA has signed the €170m deal. <div title="Page 1" class="page"><div class="layoutArea"><div class="column"></div></div></div>